GGrantIndex
← Search

VALIDATION OF ERG AS A THERAPEUTIC TARGET IN ADVANCED PROSTATE CANCER

$783,000FY2011Department of the ArmyDOD

Beth Israel Deaconess Medical Center, Inc.

Investigators

View source on USAspending →
VALIDATION OF ERG AS A THERAPEUTIC TARGET IN ADVANCED PROSTATE CANCER · GrantIndex